HALEON UK HOLDING SRI LANKA LIMITED
Company number 09400298
- Company Overview for HALEON UK HOLDING SRI LANKA LIMITED (09400298)
- Filing history for HALEON UK HOLDING SRI LANKA LIMITED (09400298)
- People for HALEON UK HOLDING SRI LANKA LIMITED (09400298)
- More for HALEON UK HOLDING SRI LANKA LIMITED (09400298)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
25 Nov 2022 | PSC05 | Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022 | |
15 Aug 2022 | CH01 | Director's details changed for Mr Lee Di Pietro on 7 July 2022 | |
18 Jul 2022 | AD01 | Registered office address changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022 | |
20 Jun 2022 | AA | Audit exemption subsidiary accounts made up to 31 December 2021 | |
20 Jun 2022 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/21 | |
20 Jun 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/21 | |
20 Jun 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/21 | |
24 May 2022 | CS01 | Confirmation statement made on 24 May 2022 with no updates | |
06 Apr 2022 | TM02 | Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a secretary on 6 April 2022 | |
06 Apr 2022 | TM01 | Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022 | |
06 Apr 2022 | TM01 | Termination of appointment of Glaxo Group Limited as a director on 6 April 2022 | |
06 Apr 2022 | AP02 | Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022 | |
06 Apr 2022 | AP04 | Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a secretary on 6 April 2022 | |
06 Apr 2022 | AP02 | Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022 | |
09 Mar 2022 | TM01 | Termination of appointment of David John Cottam as a director on 4 March 2022 | |
09 Mar 2022 | TM01 | Termination of appointment of Nicholas Ian Cooper as a director on 4 March 2022 | |
09 Mar 2022 | AP01 | Appointment of Mr Lee Di Pietro as a director on 4 March 2022 | |
09 Mar 2022 | AP01 | Appointment of Miss Rebecca Jane Leeke as a director on 4 March 2022 | |
25 Jan 2022 | CS01 | Confirmation statement made on 19 January 2022 with no updates | |
06 Jul 2021 | AA | Audit exemption subsidiary accounts made up to 31 December 2020 | |
25 May 2021 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/20 | |
25 May 2021 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/20 | |
25 May 2021 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/20 | |
19 Jan 2021 | CS01 | Confirmation statement made on 19 January 2021 with no updates | |
12 Aug 2020 | AP01 | Appointment of Mr David John Cottam as a director on 31 July 2020 |